| Q36279457 | (123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis |
| Q41113219 | 71-year-old male with progressive dyspnoea and peripheral oedema: a case of cardiac amyloidosis |
| Q92913775 | 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications |
| Q37433995 | A case of femoral compressive neuropathy in AL amyloidosis |
| Q46221880 | A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine |
| Q35579122 | A case report of localized gastric amyloidosis |
| Q89145004 | A case study of likely wild-type cardiac transthyretin amyloidosis causing rapid deterioration |
| Q28304183 | A child with raccoon eyes masquerading as trauma |
| Q38009325 | A concise review of amyloidosis in animals |
| Q47096627 | A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time |
| Q58011045 | A new transthyretin variant (Glu61Gly) associated with cardiomyopathy |
| Q35754656 | A novel amyloidogenic variant of apolipoprotein AI: implications for a conformational change leading to cardiomyopathy |
| Q77504171 | A rare case of painless gross hematuria: primary localized AA-type amyloidosis of the urinary bladder |
| Q42580998 | A rare cause of dysphagia and gastroparesis |
| Q44927886 | A rare transthyretin mutation (Asp18Glu) associated with cardiomyopathy |
| Q42028045 | A residue-specific shift in stability and amyloidogenicity of antibody variable domains |
| Q46605735 | A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing |
| Q33165133 | A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis |
| Q40659919 | A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK. |
| Q41198455 | A young adult presenting with granulomatous hepatitis and nephrotic syndrome: A case report |
| Q80003916 | AA amyloidosis in psoriatic arthritis |
| Q27678369 | AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin |
| Q84569802 | AL amyloidosis with IgD-lambda monoclonal gammopathy and lambda-type Bence-Jones protein: successful treatment by autologous stem cell transplantation |
| Q36272786 | AL cardiac amyloidosis and arterial thromboembolic events |
| Q52983766 | AL-type amyloidosis with homogeneous bile duct thickening showing biliary sclerosing changes. |
| Q92842298 | AMYLOID GOITER AS THE FIRST RECOGNIZABLE MANIFESTATION OF IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS |
| Q35592671 | APOA1 related amyloidosis: a case report and literature review |
| Q58274063 | Abnormalities in thrombin-antithrombin pathway in AL amyloidosis |
| Q84959635 | Absent skeletal uptake of (99m)Tc-hydroxymethylene diphosphonate in the presence of AL-type amyloidosis associated with multiple myeloma |
| Q64930552 | Accelerated pre-senile systemic amyloidosis in PACAP knockout mice - a protective role of PACAP in age-related degenerative processes. |
| Q35085505 | Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases |
| Q41787616 | Acute limb ischemia in a patient with cardiac amyloidosis: a case report |
| Q33819492 | Acute small bowel pseudo-obstruction due to AL amyloidosis: a case report and literature review |
| Q43986300 | Ambulatory treatment with intravenous norepinephrine in a patient with end stage renal disease and generalized AA amyloidosis |
| Q91740558 | Amyloid Goiter in a Patient with Rheumatoid Arthritis and End-Stage Renal Disease |
| Q36285971 | Amyloid angiopathy of the floor of the mouth: a case report and review of the literature |
| Q98893852 | Amyloid goiter - A rare case report and literature review |
| Q46633298 | Amyloid goiter in a case of systemic amyloidosis secondary to ankylosing spondylitis |
| Q24531062 | Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management |
| Q35588349 | Amyloid in the cardiovascular system: a review |
| Q39655910 | Amyloid light-chain amyloidosis presenting as abdominal bloating: a case report |
| Q36035620 | Amyloid peptide channels |
| Q33894236 | Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease |
| Q33334024 | Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. |
| Q30493710 | Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. |
| Q77061406 | Amyloidosis |
| Q58564782 | Amyloidosis Presenting with Macroglossia |
| Q42095765 | Amyloidosis involving the respiratory system: 5-year's experience of a multi-disciplinary group's activity |
| Q36498412 | Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience |
| Q39297480 | Amyloidosis: A story of how inframammary erosions eclipsed inconspicuous periorbital ecchymoses |
| Q37192369 | Amyloïdosis, sarcoidosis and systemic lupus erythematosus |
| Q34287707 | An Elderly Man With Progressive Dyspnea on Exertion and Atrial Fibrillation as Manifestations of Senile Cardiac Amyloidosis |
| Q34435465 | An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis |
| Q36796940 | An unusual case of cardiac amyloidosis |
| Q54998184 | An unusual etiology of plummer-Vinson syndrome. |
| Q87223371 | Analysis of serum transthyretin by on-line immunoaffinity solid-phase extraction capillary electrophoresis mass spectrometry using magnetic beads |
| Q87014743 | Analysis of transthyretin in human serum by capillary zone electrophoresis electrospray ionization time-of-flight mass spectrometry. Application to familial amyloidotic polyneuropathy type I |
| Q35745765 | Antibody-mediated resolution of light chain-associated amyloid deposits. |
| Q85158431 | Association between clinical characteristics and AL amyloid deposition in the kidney |
| Q47576488 | Atraumatic Splenic Rupture Due to Ectopic Extramedullary Hematopoiesis after Autologous Stem Cell Transplantation in a Patient with AL Amyloidosis |
| Q37416505 | Atraumatic splenic rupture in amyloidosis |
| Q41724575 | Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role |
| Q77846870 | Atrial thrombosis in cardiac amyloidosis: diagnostic contribution of transesophageal echocardiography |
| Q52666423 | Autologous Stem Cell Transplantation in Patients With Primary Systemic Amyloidosis: Experience of a Tertiary Hospital. |
| Q42179759 | Autologous stem cell transplant for Al amyloidosis |
| Q52957346 | Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. |
| Q36089654 | Autonomic peripheral neuropathy |
| Q35210255 | Axon-reflex based nerve fiber function assessment in the detection of autonomic neuropathy |
| Q44296366 | Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosis |
| Q34173828 | Biological features of the clone involved in primary amyloidosis (AL). |
| Q43089781 | Bladder perforation secondary to primary systemic amyloidosis |
| Q64360625 | Bone Marrow Core Biopsy Specimens in AL (Primary) Amyloidosis: A Morphologic and Immunohistochemical Study of 100 Cases |
| Q58030146 | Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects |
| Q40918755 | Bortezomib with dexamethasone as first-line treatment for AL amyloidosis with renal involvement |
| Q33417805 | Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis |
| Q36491277 | Bullous amyloidosis of the oral cavity: a rare clinical presentation and review |
| Q92061632 | Burden of hereditary transthyretin amyloidosis on quality of life |
| Q34936088 | C-src enriched serum microvesicles are generated in malignant plasma cell dyscrasia |
| Q36384780 | Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan |
| Q36289604 | Cancer-testis antigen expression and immunogenicity in AL amyloidosis |
| Q73236667 | Cardiac Amyloidosis |
| Q37770112 | Cardiac amyloidosis: an approach to diagnosis and management |
| Q85076497 | Cardiac amyloidosis: evolving approach to diagnosis and management |
| Q37899075 | Cardiac amyloidosis: the heart of the matter |
| Q37020261 | Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis |
| Q35535955 | Cardiovascular magnetic resonance for amyloidosis |
| Q48183224 | Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy. |
| Q39162492 | Cellular Regulation of Amyloid Formation in Aging and Disease |
| Q82028949 | Chapter 42 Specific painful neuropathies |
| Q93103912 | Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging |
| Q78629031 | Cholestasis and renal failure in a patient with secondary amyloidosis |
| Q35121614 | Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy |
| Q90622988 | Clinical and endoscopic manifestations of gastrointestinal amyloidosis: a case series |
| Q36422694 | Clinical characteristics of amyloidosis with isolated respiratory system involvement: A review of 13 cases |
| Q35834954 | Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience |
| Q48628498 | Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses |
| Q37096327 | Confocal Cornea Microscopy Detects Involvement of Corneal Nerve Fibers in a Patient with Light-Chain Amyloid Neuropathy Caused by Multiple Myeloma: A Case Report |
| Q34009881 | Conformational Abs recognizing a generic amyloid fibril epitope |
| Q46365967 | Contribution of human smooth muscle cells to amyloid angiopathy in AL (light-chain) amyloidosis. |
| Q35964900 | Current perspectives on cardiac amyloidosis |
| Q35460974 | Current status of endomyocardial biopsy |
| Q41714209 | Decrease of B-type natriuretic peptide to less than 200 pg/mL predicts longer survival in cardiac immunoglobulin light chain amyloidosis |
| Q42791436 | Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: Role of electron microscopy and Congo red stained cell block sections |
| Q49107820 | Detection of early systolic dysfunction with strain rate imaging in a patient with light chain cardiomyopathy. |
| Q38191519 | Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis |
| Q92025482 | Diagnosis and Management of a Cardiac Amyloidosis Case Mimicking Hypertrophic Cardiomyopathy |
| Q34555067 | Diagnosis and management of neuropathies associated with plasma cell dyscrasias. |
| Q59793119 | Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers |
| Q40446841 | Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis. |
| Q93121211 | Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis |
| Q74048660 | Diagnostic strategy in amyloidosis |
| Q50499373 | Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. |
| Q35664621 | Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study |
| Q37699944 | Diffuse Hepatic and Spleen Uptake of Tc-99m MDP on Bone Scintigraphy Resembling Liver-Spleen Scintigraphy in a Patient of Plasma Cell Tumor. |
| Q41688655 | Diffuse retroperitoneal amyloidosis due to renal cell carcinoma |
| Q44774534 | Diffuse scalp alopecia in a middle-aged patient |
| Q61796595 | Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis |
| Q37915513 | Dysregulation of miRNAs in AL amyloidosis |
| Q41606174 | Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: A combined NMR and in silico study. |
| Q40028003 | Embolic infarction associated with cardiac amyloidosis |
| Q38567243 | Endoscopic and histopathological features of gastrointestinal amyloidosis |
| Q54127915 | Enhancement of AA-amyloid formation in mice by transthyretin amyloid fragments and polyethylene glycol. |
| Q45844390 | Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization |
| Q40247804 | Evaluation of the mean platelet volume in secondary amyloidosis due to familial Mediterranean fever |
| Q40077972 | Evaluation of upper abdominal organs with DWI in patients with familial Mediterranean fever |
| Q47437226 | Extracellular volume with bolus-only technique in amyloidosis patients: Diagnostic accuracy, correlation with other clinical cardiac measures, and ability to track changes in amyloid load over time |
| Q36524933 | Familial Transthyretin Amyloidosis with Variant Asp38Ala Presenting with Orthostatic Hypotension and Chronic Diarrhea |
| Q90164488 | Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation |
| Q36901282 | Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction |
| Q34283400 | Formation of amyloid fibers by monomeric light chain variable domains |
| Q26776120 | Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure |
| Q98735498 | Functional Reciprocity of Amyloids and Antimicrobial Peptides: Rethinking the Role of Supramolecular Assembly in Host Defense, Immune Activation, and Inflammation |
| Q42835576 | Gastric outlet obstruction due to gastric amyloidosis mimicking malignancy in a patient with ankylosing spondylitis |
| Q46144079 | Gastrointestinal Amyloidosis: Approach to Treatment |
| Q48115785 | Gastrointestinal perforation in light chain amyloidosis in the era of novel agent therapy - a case series and review of the literature. |
| Q44135752 | Gender-related risk of myocardial involvement in systemic amyloidosis. |
| Q37083158 | Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). |
| Q46533922 | Genotype, echocardiography, and survival in familial transthyretin amyloidosis. |
| Q90481216 | Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis |
| Q33301336 | Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis |
| Q55058605 | Guidelines on the diagnosis and investigation of AL amyloidosis. |
| Q44924110 | Guidelines on the diagnosis and management of AL amyloidosis |
| Q46719529 | Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis. |
| Q47362533 | Heme-oxygenase-1 response, a marker of oxidative stress, in a mouse model of AA amyloidosis |
| Q41601916 | Hepatic Amyloidosis: Something That Can camouflage and Deceive our Perception! |
| Q74069934 | Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features |
| Q37246780 | Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. |
| Q33305656 | Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains |
| Q46227196 | High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients |
| Q31032765 | High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial |
| Q90841433 | High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review |
| Q45164371 | High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study |
| Q36887505 | How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases |
| Q50564939 | How to diagnose cardiac amyloidosis early: impact of ECG, tissue Doppler echocardiography, and myocardial biopsy. |
| Q83567869 | How to treat patients with systemic amyloid light chain amyloidosis? Comparison of high-dose melphalan, low-dose chemotherapy and no chemotherapy in patients with or without cardiac amyloidosis |
| Q33545470 | Hypertrophic and restrictive cardiomyopathies in the elderly |
| Q30968181 | Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis |
| Q57792069 | Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light chain amyloidosis |
| Q34417615 | Idiopathic AL amyloidosis and biclonal paraproteinemia: a case report and review of the literature |
| Q50192646 | Imaging cardiac innervation in amyloidosis. |
| Q39390119 | Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity |
| Q42962110 | Immunoglobulin Free Light Chains and GAGs Mediate Multiple Myeloma Extracellular Vesicles Uptake and Secondary NfκB Nuclear Translocation. |
| Q51534488 | Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosis. |
| Q33929855 | Immunoglobulin related amyloidosis presenting as isolated lymph node and pulmonary involvement |
| Q46919350 | Implantation of a cardioverter-defibrillator in a patient with cardiac amyloidosis |
| Q92482901 | Improvement of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with amyloid light-chain cardiac amyloidosis: a case report |
| Q44595334 | In vitro and in vivo interactions of homocysteine with human plasma transthyretin. |
| Q80486794 | Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis |
| Q24815899 | Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis |
| Q41813441 | Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies--are routine investigations for systemic amyloidosis warranted? |
| Q37344629 | Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis. |
| Q49932643 | Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target? |
| Q38016736 | Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up |
| Q38549232 | Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain |
| Q88840437 | Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis |
| Q30656309 | Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis |
| Q30483215 | Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography. |
| Q38630095 | Involvement of oral tissues by AL amyloidosis: a literature review and report of eight new cases |
| Q40875420 | Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis |
| Q79258612 | Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay |
| Q73515203 | LDL-Apheresis removes serum amyloid P and A in hypercholesterolemic patients |
| Q58296764 | Lambda II immunoglobulin light chain protein in primary localized rectal amyloidosis |
| Q31117033 | Laryngeal amyloidosis: localized versus systemic disease and update on diagnosis and therapy. |
| Q46526071 | Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings |
| Q97645725 | Left and right ventricular myocardial deformation and late gadolinium enhancement: incremental prognostic value in amyloid light-chain amyloidosis |
| Q74062472 | Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction? |
| Q47878862 | Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques |
| Q40963422 | Left ventricular deformation and torsion assessed by speckle-tracking echocardiography in patients with mutated transthyretin-associated cardiac amyloidosis and the effect of diflunisal on myocardial function |
| Q38556941 | Light Chain (AL) Amyloidosis: The Journey to Diagnosis |
| Q21198863 | Light chain (AL) amyloidosis: update on diagnosis and management |
| Q64913107 | Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21-year-old patient: A case report and review. |
| Q88258192 | Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation |
| Q38056010 | Light-chain amyloidosis: SCT, novel agents and beyond |
| Q37270985 | Localized amyloidosis of the breast associated with invasive lobular carcinoma |
| Q38832546 | Localized amyloidosis of the stomach mimicking a superficial gastric cancer |
| Q41898294 | Localized amyloidosis presenting with a penile mass: a case report |
| Q30806047 | Localized amyloidosis: a survey of 35 French cases |
| Q36222562 | Localized gastric amyloidosis differentiated histologically from scirrhous gastric cancer using endoscopic mucosal resection: a case report |
| Q50244058 | Localized insulin amyloidosis with use of concentrated insulin: a potential complication |
| Q42110148 | Localized mediastinal amyloidosis: A misnomer? |
| Q35378115 | Long term results of heart transplantation in patients with amyloid heart disease |
| Q34353682 | Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis |
| Q82975012 | Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis |
| Q80245314 | Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation |
| Q73384601 | Longitudinal Myocardial Function Assessed by Tissue Velocity, Strain, and Strain Rate Tissue Doppler Echocardiography in Patients With AL (Primary) Cardiac Amyloidosis |
| Q48611676 | Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study. |
| Q64946958 | Low voltage criteria EKG as a harbinger of systemic disease. |
| Q38248110 | Lymphadenopathy as a manifestation of amyloidosis: a case series |
| Q37333390 | MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature |
| Q88589963 | MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis |
| Q58294866 | Macroglossia – not always AL amyloidosis |
| Q36666474 | Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives |
| Q38244397 | Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. |
| Q37414489 | Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition |
| Q37976241 | Mechanisms of pleural involvement in orphan diseases. |
| Q33604355 | Molecular analysis of immunoglobulin genes in multiple myeloma |
| Q39617964 | Monoclonality of infiltrating plasma cells in primary pulmonary nodular amyloidosis: detection with polymerase chain reaction |
| Q34250233 | Multimodality imaging in amyloidosis |
| Q38017208 | Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review. |
| Q40504938 | Multisystemic amyloidosis. Clinical study of 39 patients in Lebanon |
| Q90667755 | Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis |
| Q37589574 | Myocardial T1 and T2 Mapping: Techniques and Clinical Applications |
| Q96952294 | NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice |
| Q48614453 | Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan. |
| Q34567440 | Natural history of thromboembolism in AL amyloidosis |
| Q38136576 | New insights and modern treatment of AL amyloidosis |
| Q79267970 | No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement |
| Q47741820 | Nodular pulmonary amyloidosis: a complex disease with malignancy association |
| Q57026547 | Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis |
| Q35771353 | Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance |
| Q33811597 | Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases |
| Q41399989 | Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study |
| Q37642923 | Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy |
| Q34075126 | Novel approaches to the treatment of primary amyloidosis |
| Q49218963 | Oligosecretory Myeloma With Amyloidosis and Alopecia |
| Q34054880 | Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire |
| Q90085272 | Origins of a pervasive, erroneous idea: The "green birefringence" of Congo red-stained amyloid |
| Q51786246 | Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009. |
| Q40973226 | Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement |
| Q49861583 | Oxidative Post-Translational Modifications of an Amyloidogenic Immunoglobulin Light Chain Protein |
| Q81612802 | Painful peripheral neuropathies |
| Q30471463 | Pancreatic islet cell amyloidosis manifesting as a large pancreas |
| Q50937021 | Pharyngeal amyloidomas: Variable appearance on imaging. |
| Q33427726 | Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis. |
| Q56997313 | Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? |
| Q35563358 | Plasma cell dyscrasias and amyloidosis |
| Q41763870 | Plasmocytoma-induced intertriginous amyloid purpura |
| Q52597244 | Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). |
| Q27671971 | Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity |
| Q53455054 | Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis. |
| Q33243275 | Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics |
| Q46109449 | Primary (AL) amyloidosis with gastrointestinal involvement |
| Q82364377 | Primary Systemic Amyloid Light Chain Amyloidosis Decompensating After Filgrastim-Induced Mobilization and Stem-Cell Collection |
| Q74531201 | Primary amyloidosis of the stomach: EUS appearances |
| Q41915523 | Primary systemic Al amyloidosis presenting as temporal arteritis. |
| Q33147775 | Primary systemic amyloidosis |
| Q26782691 | Primary systemic amyloidosis initially presenting with digestive symptoms: a case report and review of the literature |
| Q43906600 | Primary testicular amyloidosis mimicking tumor in a cryptorchid testis |
| Q36165179 | Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis |
| Q47643557 | Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation |
| Q47801564 | Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients |
| Q48156924 | Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis. |
| Q50996613 | Prognostic significance of semiautomatic quantification of left ventricular long axis shortening in systemic light-chain amyloidosis. |
| Q39404378 | Proteostasis in cardiac health and disease. |
| Q50188875 | Pulmonary amyloidosis: radiographic finding of nodular opacities in a heavy smoker |
| Q42148286 | Pulmonary arterial hypertension in primary amyloidosis |
| Q35683163 | Pulmonary hypertension and amyloidosis--an uncommon association: a case report and review of the literature. |
| Q42877860 | Pulmonary nodular amyloidosis in a patient undergoing lobectomy: a case report. |
| Q33332285 | Pulmonary renal syndrome in childhood: a report of twenty-one cases and a review of the literature |
| Q33414463 | Purpura of the face and neck: an atypical clinical presentation revealing a hepatosplenic T cell lymphoma. |
| Q34482518 | Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis |
| Q47244728 | Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report. |
| Q37638260 | Reactive amyloidosis associated with ischial callosititis: a report with histology of ischial callosities in rhesus macaques (Macaca mulatta). |
| Q57166910 | Recent advances in understanding and treating immunoglobulin light chain amyloidosis |
| Q22254188 | Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis |
| Q47646067 | Reduced intensity allogeneic stem cell transplantation for systemic primary amyloidosis refractory to high-dose melphalan |
| Q36769403 | Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance. |
| Q33753528 | Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors. |
| Q90653131 | Regression of the Anatomic Cardiac Features of Amyloid Light Chain Cardiac Amyloidosis Accompanied by Normalization of Global Longitudinal Strain |
| Q37848210 | Renal amyloidosis in children |
| Q77800110 | Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports |
| Q38992943 | Retrobulbar blood flow and carotid intima-media thickness alteration may relate to subclinic atherosclerosis in patients with chronic inflammatory diseases. |
| Q47278693 | Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis |
| Q35802182 | Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis |
| Q30478679 | Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts |
| Q34333759 | Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils |
| Q30427332 | Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes |
| Q47731978 | Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis. |
| Q35550928 | Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. |
| Q41827130 | Secondary amyloidosis associated with multiple sclerosis |
| Q42844045 | Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor. |
| Q38211031 | Secondary intestinal amyloidosis presenting intractable hematochezia: a case report and literature review |
| Q42377785 | Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis |
| Q57420160 | Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition |
| Q46306598 | Severe intrahepatic cholestasis, erythrocytosis and hypoglycemia: unusual presenting features of systemic AL amyloidosis |
| Q53724811 | Signal-averaged electrocardiography in patients with AL (primary) amyloidosis. |
| Q34420452 | Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis |
| Q38725976 | Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis |
| Q36555882 | Skin involvement in primary systemic amyloidosis |
| Q38142895 | Small bowel amyloidosis |
| Q33796675 | Small intestinal amyloidosis: a rare cause of diverticular disease |
| Q45886416 | Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis |
| Q34026552 | Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review |
| Q85049595 | Stiff Heart Syndrome |
| Q36002205 | Subacute liver failure secondary to amyloid light-chain amyloidosis |
| Q57652800 | Subcutaneous scalp nodule as the presenting symptom of systemic light-chain amyloidosis |
| Q42932124 | Successful long-term outcome of the first combined heart and kidney transplant in a patient with systemic Al amyloidosis. |
| Q51038233 | Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion. |
| Q58124943 | Successful use of Tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis |
| Q98386491 | Sudden death in lambda light chain AL cardiac amyloidosis: a review of literature and update for clinicians and pathologists |
| Q86600255 | Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis |
| Q46476158 | Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides |
| Q80514693 | Suppression of amyloidogenesis in a mouse model by corticosteroid intervention |
| Q33157401 | Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease |
| Q33160234 | Syncope in cardiac amyloidosis and chronic ischemic heart disease: A case report |
| Q38085664 | Systemic amyloidoses |
| Q43417806 | Systemic amyloidosis and the gastrointestinal tract |
| Q42013057 | Systemic amyloidosis causing intestinal hemorrhage and pseudo-obstruction |
| Q37763504 | Systemic amyloidosis: a challenge for the rheumatologist |
| Q57259460 | Systemic amyloidosis: diagnosis before treatment |
| Q40693297 | Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom |
| Q44960748 | Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis |
| Q54127507 | Testicular amyloid deposition as a cause of secondary azoospermia. |
| Q37697277 | The Imaging Diagnosis of Less Advanced Cases of Cardiac Amyloidosis: The Relative Apical Sparing Pattern |
| Q58254228 | The amino acid sequence of an AL-protein, AL-KH, isolated from the heart of a patient with Waldenstroms macroglobulinemia and amyloidosis |
| Q36366997 | The amyloidoses: clinical features, diagnosis and treatment. |
| Q37593524 | The burden of amyloid light chain amyloidosis on health-related quality of life |
| Q41814354 | The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein |
| Q34405434 | The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies. |
| Q80531133 | The legend of the lardaceous liver |
| Q83395065 | The presence of amyloid in abdominal and oral mucosal tissues in patients initially diagnosed with multiple myeloma: a pilot study |
| Q38124071 | The prognostic significance of central hemodynamics in patients with cardiac amyloidosis |
| Q47098908 | The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis. |
| Q91873273 | The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis |
| Q40296770 | The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients |
| Q48660637 | The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis |
| Q42843261 | Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis. |
| Q58030639 | Therapeutic advances demand accurate typing of amyloid deposits |
| Q41868066 | Transanal endoscopic microsurgery: the first attempt in treatment of rectal amyloidoma |
| Q45065991 | Transthyretin Cardiac Amyloidosis |
| Q90653138 | Transthyretin Cardiac Amyloidosis: A Noninvasive Multimodality Approach to Diagnosis Using Transthoracic Echocardiography, 99m-Tc-Labeled Phosphate Bone Scanning, and Cardiac Magnetic Resonance Imaging |
| Q39547833 | Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis |
| Q43663450 | Treatment of AL amyloidosis |
| Q40623410 | Treatments for amyloidosis beyond symptomatic care |
| Q88413950 | True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis |
| Q52650037 | Unilateral localized conjunctival amyloidosis in a patient with a history of contralateral orbit/eyelid lymphoma. |
| Q82548364 | Urinary dysfunction and autonomic control in amyloid neuropathy |
| Q48853691 | Urine immunofixation electrophoresis remains important and is complementary to serum free light chain |
| Q46875207 | Usefulness of labial salivary gland biopsy in familial amyloid polyneuropathy Portuguese type. |
| Q78039379 | Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis |
| Q44478247 | Utility of 18F-FDG PET(/CT) in patients with systemic and localized amyloidosis. |
| Q83248384 | Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis |
| Q41822878 | Vertebra collapse due to primary amyloidosis causing neurological compromise |
| Q38536204 | Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literature. |
| Q38851025 | Viewing Extrinsic Proteotoxic Stress Through the Lens of Amyloid Cardiomyopathy |
| Q33718793 | Worming along in amyloid cardiotoxicity |
| Q83174476 | [A 65-year-old female patient with gastric outlet obstruction of unknown origin] |
| Q83497321 | [A tongue biopsy led to the diagnosis] |
| Q53513734 | [Amyloid cardiomyopathy: A rare cause of cerebral embolism] |
| Q80930543 | [Amyloid goiter] |
| Q82620976 | [Amyloidoses] |
| Q81412306 | [An unusual cause of chylothorax: primary amyloidosis] |
| Q81703393 | [Ascites revealing a multiple myeloma complicated by AL amyloidosis] |
| Q73726908 | [Cholestatic jaundice and constitutional syndrome as early manifestations of primary systemic amyloidosis] |
| Q83142588 | [Clinicopathological conferences of the SEMI] |
| Q74362926 | [Edema in lower limbs and scrotum in a 66-year-old male] |
| Q54124221 | [Epidemiologic description of amyloidosis diagnosed at the University Hospital of Rennes from 1995 to 1999]. |
| Q50638663 | [Primary tracheobronchial amyloidosis]. |
| Q73857206 | [Proptosis and orbital tumor in an 80-year old woman. Primary orbital amyloidosis] |
| Q92619264 | [Renal amyloidoses in nephrology] |
| Q50739502 | [Systemic amyloidoses]. |
| Q73085245 | [Value of the biopsy of accessory salivary glands in amyloidosis] |
| Q33889446 | α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients. |